InsideScientific Logo
Advertisement

biomarker

biomarker

Exploring Predictive Biomarkers and ERK1/2 Phosphorylation: A New Horizon in Forecasting Survival and Response to Immune Checkpoint Blockade in Glioblastoma Treatment

, , , , , , |

In this webinar, Victor Arrieta highlights the link between p-ERK activation and improved survival in rGBM patients using anti-PD-1 immunotherapy.

Read More

Quick Links

Company News

Careers

Privacy Policy

Advertising & Marketing Services


Our Mission

InsideScientific is an online environment built for scientists, researchers, lab technicians, innovators, and industry professionals. Resources include educational webinars, virtual events, interviews, training workshops, articles and more. In addition, professionals can browse our suppliers database to learn more about scientific tools, technologies, and services offered by suppliers around the globe.

Our mission is to augment scientific discovery by facilitating and continually improving the exchange of scientific information.

Scientist.com Family

InsideScientific is a Scientist.com company.

Scientist.com is the pharmaceutical industry’s leading AI-powered marketplace for outsourced R&D. The marketplace simplifies R&D sourcing, saves time and money, reduces risk and provides access to the latest innovative tools and technologies. Scientist.com operates private enterprise marketplaces for most of the world’s major pharmaceutical companies, over 80 biotechnology companies and the US National Institutes of Health (NIH).

Learn more at www.scientist.com

© Copyright 2014 -   |  InsideScientific - A Scientist.com Company  |  All Rights Reserved
LinkedInTwitter
Cookies help us deliver our services and optimize website experience. By continuing to browse this domain, you accept our terms and conditions and privacy policy. Read our privacy policy Accept
Go to Top